Viewing StudyNCT00052884



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00052884
Status: TERMINATED
Last Update Posted: 2023-06-18
First Post: 2003-01-24

Brief Title: Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
DrugAgent Toxicity by TissueOrgan
Keywords:
Name View
primary systemic amyloidosis View
drugagent toxicity by tissueorgan View